INSMED Inc Quarterly Costs and Expenses in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
INSMED Inc quarterly/annual Costs and Expenses history and growth rate from Q1 2018 to Q3 2024.
  • INSMED Inc Costs and Expenses for the quarter ending September 30, 2024 was $307M, a 35.3% increase year-over-year.
  • INSMED Inc Costs and Expenses for the twelve months ending September 30, 2024 was $1.17B, a 21.3% increase year-over-year.
  • INSMED Inc annual Costs and Expenses for 2023 was $1.01B, a 44.4% increase from 2022.
  • INSMED Inc annual Costs and Expenses for 2022 was $703M, a 24.7% increase from 2021.
  • INSMED Inc annual Costs and Expenses for 2021 was $564M, a 31.2% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.17B $307M +$80.1M +35.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $1.09B $379M +$66.5M +21.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.02B $221M +$7.63M +3.58% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.01B $262M +$51.2M +24.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $964M $227M +$31.3M +16% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $932M $313M +$159M +104% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $773M $213M +$70.4M +49.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $703M $211M +$55.6M +35.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $647M $195M +$45.1M +30% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 $602M $154M +$19.6M +14.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $582M $143M +$18.9M +15.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $564M $155M +$19.2M +14.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 $544M $150M +$50.5M +50.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 $494M $134M +$37.3M +38.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $456M $124M +$26.8M +27.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $430M $136M +$27.7M +25.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $402M $99.9M +$10.9M +12.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-28
Q2 2020 $391M $96.6M +$9.39M +10.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $382M $97.2M +$9.96M +11.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $372M $108M +$10.7M +11% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-17
Q3 2019 $361M $88.9M +$4.95M +5.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $356M $87.2M +$14.3M +19.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $342M $87.3M +$24.5M +39.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q4 2018 $317M $97.6M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $84M Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $72.9M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $62.8M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.